Legislature Returns to Sacramento in One Month


Legislature Returns to Sacramento in One Month

The California Legislature is set to return to Sacramento to resume the second year of the 2021-22 Legislative Session in one month on January 3, 2022. Lawmakers are anticipated to face a number of significant issues upon their return to the Capitol, including issues related to health and human services implementation (e.g., CalAIM, Children and…

Read More »

Assembly Convenes Two Select Committee Hearings Related to Public Health

This week, the California State Assembly convened two informational hearings related to public health in locations throughout the state. We highlight these hearings below: Hernandez Testifies at Assembly Select Committee on Social Determinants of Health On Wednesday, the Assembly Select Committee on the Social Determinants of Health convened its inaugural hearing in La Mesa in…

Read More »

WHO Names Omicron Variant of Concern, First Cases Detected in California

Last Friday, the World Health Organization (WHO) classified a new COVID-19 variant B.1.1.529, or Omicron, as a “variant of concern” following reports of cases to the WHO by South Africa. Researchers continue to study the virus mutations, its impacts on transmissibility and disease severity, and effectiveness of prior infection, vaccines, and current tests and treatments….

Read More »

White House Details COVID-19 Strategy for Winter

On Thursday, President Joseph R. Biden, Jr. announced a series of new actions to protect Americans from COVID-19, including the Delta and Omicron variants, this winter. The Administration’s new actions come as additional cases of the Omicron variant continue to be identified in the U.S. and globally. The new set of actions include: Boosters for…

Read More »

CDC Updates COVID-19 Booster Recommendations

On Monday, U.S. Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky announced the CDC has strengthened its recommendation for booster doses for individuals ages 18 and older. Per the CDC, everyone ages 18 and older should get a booster shot either when they are six months after their initial Pfizer or Moderna…

Read More »

Pfizer-BioNTech Request EUA Expansion for Adolescent Boosters

This week, Pfizer and BioNTech submitted a formal request to the U.S. Food and Drug Administration (FDA) to expand the emergency use authorization (EUA) of a booster dose of the COVID-19 vaccination to include individuals ages 16 and 17. Currently, only people ages 18 and older are eligible for a COVID-19 booster dose in the…

Read More »

DHCS Joins CMS Group on Quality Improvements for Well-Child Visits

The California Department of Health Care Services (DHCS) was recently accepted into the U.S. Centers for Medicare & Medicaid Services’ (CMS) Infant Well-Child Visits Learning Collaborative Affinity Group. The group is part of CMS’ Maternal and Infant Health Quality Initiative, which is intended to support states in implementing quality improvement projects that improve the utilization…

Read More »

FDA Panel Narrowly Recommends First Oral COVID-19 Antiviral Treatment

On Tuesday, the U.S. Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) narrowly recommended that the agency issue its first emergency use authorization (EUA) for Merck’s investigational oral antiviral medication for the treatment of mild to moderate COVID-19 in adults with high risk of severe COVID-19 or hospitalization. The drug, molnupiravir, has been…

Read More »